LN-514434
Pazopanib Related Compound 3 , 0.95 , 1252927-44-8
Update time: 2023-04-23
PRODUCT Properties
Boiling point: | 824.9±75.0 °C(Predicted) |
Density | 1.41±0.1 g/cm3(Predicted) |
pka | 3.16±0.10(Predicted) |
Description and Uses
This compound is an impurity of Pazopanib (P210925). Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.